Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers
The advent of immune checkpoint therapy for metastatic skin cancer has greatly improved patient survival. However, most skin cancer patients are refractory to checkpoint therapy, and furthermore, the intra-immune cell signaling driving response to checkpoint therapy remains uncharacterized. When com...
Main Authors: | Emmanuel Dollinger, Daniel Bergman, Peijie Zhou, Scott X. Atwood, Qing Nie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2946 |
Similar Items
-
High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy
by: Camelia Quek, et al.
Published: (2021-10-01) -
Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
by: Xinyu Bai, et al.
Published: (2022-09-01) -
Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma
by: Tao Liu, et al.
Published: (2023-07-01) -
Unravelling the landscape of skin cancer through single-cell transcriptomics
by: Ankit Srivastava, et al.
Published: (2023-01-01) -
Characterization of the Immune Microenvironment and Identification of Biomarkers in Chronic Rhinosinusitis with Nasal Polyps Using Single-Cell RNA Sequencing and Transcriptome Analysis
by: Wang Y, et al.
Published: (2024-01-01)